|
Gryphon Bio, Inc.
South San Francisco, USA
|
|
Gryphon Bio is a preclinical-stage therapeutic bioconjugate company created to harness the discovery of novel therapeutic targets and temporal biomarkers in unexpected waves of brain molecules in the blood. The company's mission is to develop and market the therapeutic bioconjugate to accelerate brain repair and improve cognition.